Prelude Capital Management’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
Other funds holding PAHC
FMI
AAMU
CSC
Prelude Capital Management's PAHC Position: Q3 2020 in Review
Prelude Capital Management sold out of Phibro Animal Health (PAHC) in Q3 2020, closing a stake of 869 shares — an estimated $23K sold.
Prelude Capital Management first reported a position in PAHC in Q3 2014 and held it in 15 quarters. The position peaked at $604K in Q1 2017. 136 funds tracked by Wall St. Rank hold PAHC as of Q3 2020.
- Prelude Capital Management reported no remaining Phibro Animal Health position as of Q3 2020 after selling out during the quarter.
- Prelude Capital Management sold 869 Phibro Animal Health shares in Q3 2020, an estimated $23K.
- Prelude Capital Management first reported a position in Phibro Animal Health in Q3 2014 and held it in 15 quarters.
- Prelude Capital Management's Phibro Animal Health position peaked at $604K in Q1 2017.
- 136 funds tracked by Wall St. Rank held Phibro Animal Health as of Q3 2020.
Based on Prelude Capital Management's 13F filing for Q3 2020, filed 16 Nov 2020.